Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    In Clinical Trial stage, Public, Small/Medium Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (1)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage (1)

    Employees (2)

    Location 

    Status 

    13 Startups 2 In the News 4 Recently Updated
    • Total Funding
      $596.78M
      Raised
      37
      Events
    • Private Funding
      $42.4M
      Raised
      4
      Rounds
    • Public Offerings
      $554.38M
      Raised
      30
      Offerings
    • M&A
      $0
      Raised
      3
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    UroGen Pharma logo

    UroGen Pharma

    Public
    Urologic Oncology Therapies
    2004 B2B 201-500 Public $414.7M
    oncology
    drug-delivery
    sustained-release
    urology
    pharmaceuticals
    orphan-drug
    non-surgical
    pharma-companies
    drug-design
    cancer
    PainReform logo

    PainReform

    Public
    Pain Treatment Drugs
    2007 B2B, B2B2C 1-10 Public $46.3M
    pharmaceuticals
    pain-relief
    generic-drugs
    drug-delivery
    patients
    life-sciences
    treatments
    therapeutics
    SciSparc logo

    SciSparc

    Public
    Cannabinoid Pharmaceuticals for Treatment of Central Nervous System Disorders
    2004 B2B 1-10 Public $32.18M
    alzheimers-disease
    epilepsy
    drug-delivery
    medical-cannabis
    therapeutics
    cancer
    chronic-disease
    immunotherapy
    chronic-pain
    pharmaceuticals
    pain-relief
    apnea
    infectious-disease
    cns-disorders
    drug-development
    autism
    Vidac Pharma logo

    Vidac Pharma

    Public
    Skin Cancer Treatment
    2012 B2B 1-10 Public $9M
    pharma-companies
    oncology
    oral-drugs
    targeted-therapy
    drug-discovery
    biotechnology
    dermatology
    drug-development
    topical-treatment
    cancer
    biopharmaceutical
    Tikcro Technologies logo

    Tikcro Technologies

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Antigen Design Technology for New Functional Blocking Antibodies
    1999 B2B 1-10 Public Undisclosed
    cancer
    pharmaceuticals
    drug-development
    biotechnology
    biopharmaceutical
    Bioblast Pharma logo

    Bioblast Pharma

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutic Agents for Rare Genetic Diseases
    2012 B2B 1-10 Public $39.75M
    biopharmaceutical
    therapeutics
    neurology
    biotechnology
    drug-discovery
    genetic-disorders
    Immune Pharmaceuticals logo

    Immune Pharmaceuticals

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Monoclonal Antibody Treatment for Cancer and Inflammatory Diseases
    2010 B2B 1-10 Public $52.7M
    oncology
    drug-delivery
    crohn's-disease
    antibodies
    cancer
    asthma
    inflammatory-diseases
    nanotechnology
    autoimmune-diseases

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    13 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $596.78M
      Raised
      37
      Events
    • Private Funding
      $42.4M
      Raised
      4
      Rounds
    • Public Offerings
      $554.38M
      Raised
      30
      Offerings
    • M&A
      $0
      Raised
      3
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    UroGen Pharma logo
    Raised
    $414.7M
    UroGen Pharma
    Public
    Urologic Oncology Therapies
    Founded:2004
    Business Model:B2B
    Employees:201-500
    Funding Stage:Public
    PainReform logo
    Raised
    $46.3M
    PainReform
    Public
    Pain Treatment Drugs
    Founded:2007
    Business Model:B2B, B2B2C
    Employees:1-10
    Funding Stage:Public
    SciSparc logo
    Raised
    $32.18M
    SciSparc
    Public
    Cannabinoid Pharmaceuticals for Treatment of Central Nervous System Disorders
    Founded:2004
    Business Model:B2B
    Employees:1-10
    Funding Stage:Public
    Vidac Pharma logo
    Raised
    $9M
    Vidac Pharma
    Public
    Skin Cancer Treatment
    Founded:2012
    Business Model:B2B
    Employees:1-10
    Funding Stage:Public
    Tikcro Technologies logo
    Raised
    Undisclosed
    Tikcro Technologies
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Antigen Design Technology for New Functional Blocking Antibodies
    Founded:1999
    Business Model:B2B
    Employees:1-10
    Funding Stage:Public
    Bioblast Pharma logo
    Raised
    $39.75M
    Bioblast Pharma
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutic Agents for Rare Genetic Diseases
    Founded:2012
    Business Model:B2B
    Employees:1-10
    Funding Stage:Public
    Immune Pharmaceuticals logo
    Raised
    $52.7M
    Immune Pharmaceuticals
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Monoclonal Antibody Treatment for Cancer and Inflammatory Diseases
    Founded:2010
    Business Model:B2B
    Employees:1-10
    Funding Stage:Public
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,